A large animal model to evaluate the effects of Hsp90 inhibitors for the treatment of lung adenocarcinoma

Virology

Volumn 371, Issue 1, 2008, Pages 206-215

  Varela, Mariana ^a   Golder, Matthew ^a   Archer, Fabienne ^b   de las Heras, Marcelo ^c   Leroux, Caroline ^b   Palmarini, Massimo ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSIDAD DE ZARAGOZA   (Spain)

Author keywords

Betaretroviruses; Jaagsiekte sheep retrovirus; Large animal models; Lung adenocaricnoma; Retroviruses; Sheep

Indexed keywords

17 DEMETHOXY 17 (2 DIMETHYLAMINOETHYLAMINO)GELDANAMYCIN; 2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 6,7 DIMETHOXY 2 PHENYLQUINOXALINE; AG 2043; ANTIVIRUS AGENT; DAMNACANTHAL; EMODIN; GELDANAMYCIN; GENISTEIN INHIBITOR 1; GENISTEIN INHIBITOR 2; HEAT SHOCK PROTEIN 90; HERBIMYCIN A; JANUS KINASE INHIBITOR; LAVENDUSTIN C; PLATELET DERIVED GROWTH FACTOR RECEPTOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR RECEPTOR INHIBITOR 2; PLATELET DERIVED GROWTH FACTOR RECEPTOR INHIBITOR 3; PROTEIN KINASE B; RADICICOL; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 2 KINASE INHIBITOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FIBROBLAST; JAAGSIEKTE SHEEP RETROVIRUS; LUNG ADENOCARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS CELL TRANSFORMATION;

ANIMALIA; JAAGSIEKTE SHEEP RETROVIRUS; OVIS; OVIS ARIES;

EID: 38049034421     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.09.041     Document Type: Article

References (48)

1. Allen T.E., Sherrill K.J., Crispell S.M., Perrott M.R., Carlson J.O., and DeMartini J.C. The Jaagsiekte sheep retrovirus envelope gene induces transformation of the avian fibroblast cell line DF-1 but does not require a conserved SH2 binding domain. J. Gen. Virol. 83 Pt 11 (2002) 2733-2742
2. Archer F., Jacquier E., Lyon M., Chastang J., Cottin V., Mornex J.F., and Leroux C. Alveolar type II cells isolated from pulmonary adenocarcinoma: a model for JSRV expression in vitro. Am. J. Respir. Cell Mol. Biol. 36 5 (2007) 534-540
3. Blagg B.S., and Kerr T.D. Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation. Med. Res. Rev. 26 3 (2006) 310-338
4. Blake R.A., Broome M.A., Liu X., Wu J., Gishizky M., Sun L., and Courtneidge S.A. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 20 23 (2000) 9018-9027
5. Brognard J., Clark A.S., Ni Y., and Dennis P.A. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 61 10 (2001) 3986-3997
6. Caporale M., Cousens C., Centorame P., Pinoni C., De las Heras M., and Palmarini M. Expression of the Jaagsiekte sheep retrovirus envelope glycoproteins is sufficient to induce lung tumor in sheep. J. Virol. 80 (2006) 8030-8037
7. Chant I.D., Rose P.E., and Morris A.G. Analysis of heat-shock protein expression in myeloid leukaemia cells by flow cytometry. Br. J. Haematol. 90 1 (1995) 163-168
8. Chow Y.H., Alberti A., Mura M., Pretto C., Murcia P., Albritton L.M., and Palmarini M. Transformation of rodent fibroblasts by the Jaagsiekte sheep retrovirus envelope is receptor independent and does not require the surface domain. J. Virol. 77 11 (2003) 6341-6350
9. Collis M.C. Integrative pharmacology and drug discovery-is the tide finally turning?. Nat. Rev. Drug Discov. 5 5 (2006) 377-379
10. De Las Heras M., Ortin A., Benito A., Summers C., Ferrer L.M., and Sharp J.M. In-situ demonstration of mitogen-activated protein kinase Erk 1/2 signalling pathway in contagious respiratory tumours of sheep and goats. J. Comp. Pathol. 135 1 (2006) 1-10
11. Digel W., and Lubbert M. DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results. Crit. Rev. Oncol. Hematol. 55 1 (2005) 1-11
12. Dutt A., and Wong K.K. Mouse models of lung cancer. Clin. Cancer Res. 12 14 Pt 2 (2006) 4396s-4402s
13. Fan H. Jaagsiekte Sheep Retrovirus and Lung Cancer (2003), Springer-Verlag, Berlin
14. Girard L., Zochbauer-Muller S., Virmani A.K., Gazdar A.F., and Minna J.D. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 60 17 (2000) 4894-4906
15. Hull S., and Fan H. Mutational analysis of the cytoplasmic tail of Jaagsiekte sheep retrovirus envelope protein. J. Virol. 80 16 (2006) 8069-8080
16. Jassim, F.A. (1988). PhD Thesis. University of Edinburgh, Edinburgh, UK.
17. Jassim F.A., Sharp J.M., and Marinello P.D. Three-step procedure for isolation of epithelial cells from the lungs of sheep with Jaagsiekte. Res. Vet. Sci. 43 3 (1987) 407-409
18. Kamal A., Thao L., Sensintaffar J., Zhang L., Boehm M.F., Fritz L.C., and Burrows F.J. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425 6956 (2003) 407-410
19. Karni R., Mizrachi S., Reiss-Sklan E., Gazit A., Livnah O., and Levitzki A. The pp60c-Src inhibitor PP1 is non-competitive against ATP. FEBS Lett. 537 1-3 (2003) 47-52
20. Khanna C., Lindblad-Toh K., Vail D., London C., Bergman P., Barber L., Breen M., Kitchell B., McNeil E., Modiano J.F., Niemi S., Comstock K.E., Ostrander E., Westmoreland S., and Withrow S. The dog as a cancer model. Nat. Biotechnol. 24 9 (2006) 1065-1066
21. Kolch W. Ras/Raf signalling and emerging pharmacotherapeutic targets. Expert Opin. Pharmacother. 3 6 (2002) 709-718
22. Liu S.L., Lerman M.I., and Miller A.D. Putative phosphatidylinositol 3-kinase (PI3K) binding motifs in ovine betaretrovirus Env proteins are not essential for rodent fibroblast transformation and PI3K/Akt activation. J. Virol. 77 14 (2003) 7924-7935
23. Maeda N., Palmarini M., Murgia C., and Fan H. Direct transformation of rodent fibroblasts by Jaagsiekte sheep retrovirus DNA. Proc. Natl. Acad. Sci. U. S. A. 98 8 (2001) 4449-4454
24. Maeda N., Inoshima Y., Fruman D.A., Brachmann S.M., and Fan H. Transformation of mouse fibroblasts by Jaagsiekte sheep retrovirus envelope does not require phosphatidylinositol 3-kinase. J. Virol. 77 (2003) 9951-9959
25. Maeda N., Fu W., Ortin A., de las Heras M., and Fan H. Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in Jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines. J. Virol. 79 7 (2005) 4440-4450
26. Minna J.D., Roth J.A., and Gazdar A.F. Focus on lung cancer. Cancer Cells 1 1 (2002) 49-52
27. Mornex J.F., Thivolet F., De las Heras M., and Leroux C. Pathology of human bronchioloalveolar carcinoma and its relationship to the ovine disease. Curr. Top. Microbiol. Immunol. 275 (2003) 225-248
28. Palmarini M., and Fan H. Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer. J. Natl. Cancer Inst. 93 21 (2001) 1603-1614
29. Palmarini M., and Fan H. Molecular biology of Jaagsiekte sheep retrovirus. Curr. Top. Microbiol. Immunol. 275 (2003) 81-115
30. Palmarini M., Sharp J.M., De las Heras M., and Fan H. Jaagsiekte sheep retrovirus is necessary and sufficient to induce a contagious lung cancer in sheep. J. Virol. 73 (1999) 6964-6972
31. Palmarini M., Maeda N., Murgia C., De-Fraja C., Hofacre A., and Fan H. A phosphatidylinositol 3-kinase docking site in the cytoplasmic tail of the Jaagsiekte sheep retrovirus transmembrane protein is essential for envelope-induced transformation of NIH 3T3 cells. J. Virol. 75 22 (2001) 11002-11009
32. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 2 (2005) 74-108
33. Rai S.K., Duh F.M., Vigdorovich V., Danilkovitch-Miagkova A., Lerman M.I., and Miller A.D. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for Jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc. Natl. Acad. Sci. U. S. A. 98 8 (2001) 4443-4448
34. Rothenberg M.L., Carbone D.P., and Johnson D.H. Improving the evaluation of new cancer treatments: challenges and opportunities. Nat. Rev., Cancer 3 4 (2003) 303-309
35. Salvatori D., Gonzalez L., Dewar P., Cousens C., de las Heras M., Dalziel R.G., and Sharp J.M. Successful induction of ovine pulmonary adenocarcinoma in lambs of different ages and detection of viraemia during the preclinical period. J. Gen. Virol. 85 Pt 11 (2004) 3319-3324
36. Santarosa M., Favaro D., Quaia M., and Galligioni E. Expression of heat shock protein 72 in renal cell carcinoma: possible role and prognostic implications in cancer patients. Eur. J. Cancer 33 6 (1997) 873-877
37. Sato S., Fujita N., and Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc. Natl. Acad. Sci. U. S. A. 97 20 (2000) 10832-10837
38. Senju M., Sueoka N., Sato A., Iwanaga K., Sakao Y., Tomimitsu S., Tominaga M., Irie K., Hayashi S., and Sueoka E. Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines. J. Cancer Res. Clin. Oncol. 132 3 (2006) 150-158
39. Sharp J.M., Angus K.W., Gray E.W., and Scott F.M. Rapid transmission of sheep pulmonary adenomatosis (Jaagsiekte) in young lambs. Brief report. Arch. Virol. 78 1-2 (1983) 89-95
40. Suau F., Cottin V., Archer F., Croze S., Chastang J., Cordier G., Thivolet-Bejui F., Mornex J.F., and Leroux C. Telomerase activation in a model of lung adenocarcinoma. Eur. Respir. J. 27 6 (2006) 1175-1182
41. Timpson P., Jones G.E., Frame M.C., and Brunton V.G. Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity. Curr. Biol. 11 23 (2001) 1836-1846
42. Varela M., Chow Y.H., Sturkie C., Murcia P., and Palmarini M. Association of RON tyrosine kinase with the Jaagsiekte sheep retrovirus envelope glycoprotein. Virology 350 2 (2006) 347-357
43. Varmus H., Pao W., Politi K., Podsypanina K., and Du Y.C. Oncogenes come of age. Cold Spring Harbor Symp. Quant. Biol. 70 (2005) 1-9
44. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev., Cancer 2 7 (2002) 489-501
45. Wootton S.K., Halbert C.L., and Miller A.D. Sheep retrovirus structural protein induces lung tumours. Nature 434 7035 (2005) 904-907
46. Workman P. Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone. Cancer Lett. 206 2 (2004) 149-157
47. Yufu Y., Nishimura J., and Nawata H. High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells. Leuk. Res. 16 6-7 (1992) 597-605
48. Zhang J., Kalyankrishna S., Wislez M., Thilaganathan N., Saigal B., Wei W., Ma L., Wistuba II, Johnson F.M., and Kurie J.M. SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines. Am. J. Pathol. 170 1 (2007) 366-376